XML 73 R37.htm IDEA: XBRL DOCUMENT v3.20.2
Intangible Assets - Additional Information (Detail) - USD ($)
12 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2018
Finite Lived Intangible Assets [Line Items]      
Amortization expense $ 1,700,429 $ 1,700,430 $ 1,700,429
Amortization of license agreements remainder of fiscal year 2021 1,700,429    
Amortization of license agreements in 2022 1,700,429    
Amortization of license agreements in 2023 1,700,429    
Amortization of license agreements in 2024 1,700,429    
Amortization of license agreements in 2025 1,700,429    
Amortization of license agreements, thereafter $ 6,861,006    
Novartis | Licensing Agreement      
Finite Lived Intangible Assets [Line Items]      
Amortization period of intangible assets 21 years    
Finite-lived intangible assets, accumulated amortization $ 828,596    
Novartis | Patents      
Finite Lived Intangible Assets [Line Items]      
Amortization period of intangible assets 14 years    
Finite-lived intangible assets, accumulated amortization $ 8,665,466